论文信息 - Oral Revlimid® Plus Melphalan and Prednisone (R-MP) for Newly Diagnosed Multiple Myeloma: Results of a Multicenter Phase I/II Study. - 字舞流文

Oral Revlimid® Plus Melphalan and Prednisone (R-MP) for Newly Diagnosed Multiple Myeloma: Results of a Multicenter Phase I/II Study.

R. Foà | M. Boccadoro | G. Rossi | J. Zeldis | F. Morabito | L. Canepa | F. Raimondo | A. Palumbo | M. Petrucci | P. Corradini | N. Giuliani | R. Knight | A. Gozzetti | A. Falcone | P. Falco | M. T. Ambrosini